New Cannabix Breath Collection Unit (BCU)
New Cannabix Breath Collection Unit (BCU)
  • Cannabix Technologies (BLO) is participating in a new comprehensive multi-analysis study of human subjects under the influence of marijuana
  • The new study will work along side toxicologists and law enforcement officers in the southern United States
  • Cannabix has granted use of its Breath Collection Unit and newly developed laboratory “MS Breath Sampler” equipment to this important new research study
  • Cannabix Technologies develops marijuana breathalyzer technologies for law enforcement and the workplace
  • Cannabix Technologies Inc. (BLO) is up 7.41 per cent, trading at C$0.435 per share at 12:02 pm ET

Cannabix Technologies (BLO) is participating in a new comprehensive multi-analysis study of human subjects under the influence of marijuana.

The new study will work along side toxicologists and law enforcement officers in the southern United States. The study tests subject under the influence of marijuana alongside several conventional drug screening methods (blood, oral fluid etc.). 

Cannabix has granted use of its Breath Collection Unit and newly developed laboratory “MS Breath Sampler” equipment to this important new research study. It is building upon recent independent study results that showed excellent correlation between blood plasma THC and breath samples collected and analyzed with Cannabix equipment.

This study provides a critical launch point for Cannabix devices regarding law enforcement and toxicology audience. Breath testing for THC would allow law enforcement to quickly and practically identify recent marijuana use that aligns with the timing window of impairment, unlike other technologies such as saliva or urine.

According to the NHTSA report to congress (2017), THC in the blood drops rapidly after smoking cessation. In contrast to alcohol which metabolizes at a relatively steady rate, THC metabolizes at an exponentially declining rate. THC blood level first drops rapidly, then slowly decreases, reaching lower THC levels. After a few hours, only low or no THC can be detected in blood.

Confirmation of drug presence as quickly as possible after the time of a law enforcement stop is paramount. It increases the chance of convictions for drugged driving. Cannabix equipment can help reduce the time to confirm drug presence with easy-to-collect breath samples using breath analysis techniques that law enforcement officers are already familiar with.

Cannabix Technologies develops marijuana breathalyzer technologies for law enforcement and the workplace. It is developing drug-screening devices that will detect THC – the psychoactive component of marijuana that causes impairment using breath samples.

Cannabix Technologies Inc. (BLO) is up 7.41 per cent, trading at C$0.435 per share at 12:02 pm ET.

More From The Market Online

PharmAla Biotech launches educational portal for MDMA

PharmAla Biotech (CSE:MDMA) launches its Prescribers Portal for medical practitioners to learn more about MDMA.

Cancer-fighting pharma stock eyes 2027 regulatory approval

Theralase Technologies (TSXV:TLT), a cancer-fighting pharma stock, expands its team with two clinical research associates.

PharmaDrug-PharmaTher Holdings JV submits clinical, regulatory package

Sairiyo Therapeutics, a PharmaDrug (CSE:PHRX) and PharmaTher Holdings (CSE:PHRM) joint venture, pursues a human clinical study in Australia.